(Q34140917)

31 July 2017

1 reference

title

Angiozyme: a novel angiogenesis inhibitor (English)

1 reference

31 July 2017

main subject

angiogenesis inhibitor

1 reference

Weng DE

1

1 reference

31 July 2017

Usman N

series ordinal

2

1 reference

31 July 2017

publication date

1 March 2001

1 reference

31 July 2017

published in

Current Oncology Reports

1 reference

31 July 2017

volume

3

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

141-146

1 reference

Cellular Uptake Properties of a 2‵-Amino/2‵-O-Methyl-Modified Chimeric Hammerhead Ribozyme Targeted to the Epidermal Growth Factor Receptor mRNA

31 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007/S11912-001-0014-7

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

21 January 2018

1 reference

12 December 2020

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

1 reference

12 December 2020

Clinical applications of angiogenic growth factors and their inhibitors

1 reference

12 December 2020

Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours

1 reference

12 December 2020

Pharmacokinetics of an antiangiogenic ribozyme (ANGIOZYME) in the mouse

1 reference

12 December 2020

A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis

1 reference

12 December 2020

Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors

1 reference

12 December 2020

Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells

1 reference

12 December 2020

The Tetrahymena ribozyme acts like an RNA restriction endonuclease

1 reference

12 December 2020

Tumor angiogenesis and recurrence in stage I non-small cell lung cancer

1 reference

12 December 2020

Tumor angiogenesis: therapeutic implications

1 reference

12 December 2020

Vascular endothelial growth factor as prognostic factor in renal cell carcinoma

1 reference

12 December 2020

Bioactivity of anti-angiogenic ribozymes targeting Flt-1 and KDR mRNA.

1 reference

12 December 2020

Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant Treatment

1 reference

12 December 2020

Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues

1 reference

12 December 2020

Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF

1 reference

12 December 2020

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

1 reference

12 December 2020

Role of VEGF-flt receptor system in normal and tumor angiogenesis.

1 reference

12 December 2020

Hammerhead ribozyme engineering

1 reference

12 December 2020

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

12 December 2020

Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications

1 reference

12 December 2020

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

12 December 2020

Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells

1 reference

12 December 2020

Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma

1 reference

12 December 2020

A catalytic RNA and its gene from Salmonella typhimurium

1 reference

12 December 2020

Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival

1 reference

12 December 2020

Factors promoting tumor angiogenesis

1 reference

12 December 2020

Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo

1 reference

12 December 2020

10.1007/S11912-001-0014-7

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1042244601

0 references

Fatcat ID

release_5sowc2r7lzgrbljyb6b6g2ym5u

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5sowc2r7lzgrbljyb6b6g2ym5u

24 November 2022

mapped directly with Wikidata item

1 reference